CN EN
Advanced

When are applied patents more valuable than granted patents?

Abstract

Building on the real options logic, we posit that applied patents play a greater role than granted patents in enabling technology ventures to raise capital in initial public offerings (IPOs). Compared with a venture’s granted patents, its applied patents have more call options (e.g., broader protection claims, higher flexibility in resource commitments, and longer exercise time), and thus are more valuable according to the real options logic. We suggest that younger ventures are better able to identify and create value from the options in their applied patents, given their entrepreneurial abilities. We also argue that ventures with more advanced milestones in product development are better able to capture value from the options in their applied patents, given their commercialization capabilities. We analyze data from 251 biotechnology ventures undertaking IPOs in the U.S. during 2004-2015, and find overall evidence for these hypotheses. This study contributes to management and innovation research by theoretically and empirically examining the distinctive roles of applied patents and granted patents in influencing IPO proceeds.

Keyword

Author Community

[Wang, Taiyuan] China Europe International Business School

[Shu, Chengli] U. of Adelaide

[Deeds, David] U. of St. Thomas


Related Article

Source

ISSN:0065-0668

Year:2019

Issue:1

Volume:2019

Language:English

Cited Count
W
Loading...
C
Loading...
Get Fulltext
Rights and Licenses
Related Keywords
Communities & Collections
Access Stats
Creative Commons Licence
The content of CEIBS Research Online is licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).